This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Kemyth Biotech Co., Ltd.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Leung-Kei Siu: Innovator in Antibiotic Testing and Diabetes Treatment
Introduction
Leung-Kei Siu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the fields of antibiotic testing and diabetes treatment. With a total of 2 patents, his work focuses on developing innovative solutions to combat pressing health issues.
Latest Patents
One of his latest patents is an antibiotic testing and screening system. This invention provides a platform technology for testing, screening, selecting, and evaluating antibiotics using genetically engineered strains with identified resistance mechanisms. It is designed to efficiently evaluate antibiotics against specified resistance mechanisms both in vitro and in vivo, making it suitable for novel antibiotic development against multidrug-resistant bacteria.
Another notable patent relates to the treatment of diabetes through toll-like receptor 4 (TLR-4) modulators. This invention introduces an isolated peptide from pneumolysin (PLY peptide), which is effective in treating diabetes. The PLY peptide acts as a TLR-4 antagonist, offering potential treatment options for diseases associated with TLR-4 activation.
Career Highlights
Leung-Kei Siu is currently associated with Kemyth Biotech Co., Ltd., where he continues to innovate in the biotechnology sector. His work is pivotal in addressing critical health challenges through advanced research and development.
Collaborations
He has collaborated with notable coworkers, including Yu-Kuo Tsai and Pele Choi-Sing Chong, contributing to the advancement of their shared goals in biotechnology.
Conclusion
Leung-Kei Siu's contributions to antibiotic testing and diabetes treatment highlight his role as a key innovator in the field. His patents reflect a commitment to addressing significant health issues through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile